Phase 2, Multi-center, Open-label Trial to Evaluate Efficacy and Safety of GM-CT-01 in Combination With 5-FU as First Line Chemotherapy in Patients With Advanced Biliary Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Galactomannan C (Primary) ; Fluorouracil
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- Sponsors Galectin Therapeutics
- 31 Jul 2017 Status changed from discontinued to withdrawn prior to enrolment.
- 09 Mar 2012 Actual patient number 17 added as reported by ClinicalTrials.gov.
- 09 Mar 2012 Actual end date Jun 2009 added as reported by ClinicalTrials.gov.